GENETIC TOXICOLOGY OF MITOMYCIN-C, ACTINOMYCINS, DAUNOMYCIN AND ADRIAMYCIN

被引：45
|
作者：
VIG, BK
机构：
[1] NEVADA MENTAL HLTH INST, RENO, NV 89505 USA
[2] UNIV NEVADA, DEPT BIOL, RENO, NV 89557 USA
来源：
MUTATION RESEARCH | 1977年 / 39卷 / 02期
关键词：
D O I：
10.1016/0165-1110(77)90022-7
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：189 / 238
页数：50
相关论文
共 50 条
  • [31] COMBINATION CHEMOTHERAPY OF GASTRIC CANCER WITH FLUORO-URACIL, ADRIAMYCIN AND MITOMYCIN-C (FAM)
    SCHEIN, PS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1977, 3 : S29 - S29
  • [32] ADRIAMYCIN (DOXORUBICIN), VINBLASTINE, AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN REFRACTORY BREAST-CARCINOMA
    LUIKART, SD
    WITMAN, GB
    PORTLOCK, CS
    CANCER, 1984, 54 (07) : 1252 - 1255
  • [33] FLUOROURACIL (F), ADRIAMYCIN (A) AND MITOMYCIN-C (M), FAM, FOR ADENOCARCINOMA OF UNKNOWN ORIGIN (AUO)
    MCKEEN, E
    SMITH, F
    HAIDAK, D
    BUTLER, T
    HOTH, D
    WOOLLEY, P
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 358 - 358
  • [34] PERMEABILITY OF THE RAT BLADDER TO CISPLATINUM UNDER DIFFERENT CONDITIONS - COMPARISON WITH MITOMYCIN-C AND ADRIAMYCIN
    ENGELMANN, U
    OELSNER, G
    BURGER, RA
    WAGNER, H
    UROLOGICAL RESEARCH, 1983, 11 (01): : 39 - 42
  • [35] 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) IN THE TREATMENT OF INOPERABLE ADENOCARCINOMA OF THE LUNG
    SHEPHERD, FA
    EVANS, WK
    BURKES, R
    PAUL, K
    DEBOER, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (05): : 392 - 396
  • [36] CHARACTERIZATION OF LIPOSOMES AND AN EMULSION CONTAINING MITOMYCIN-C OR LIPOPHILIC MITOMYCIN-C PRODRUGS
    SASAKI, H
    KAKUTANI, T
    HASHIDA, M
    SEZAKI, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1986, 75 (12) : 1166 - 1170
  • [37] ENDOVESICAL CHEMOTHERAPY WITH ADRIAMYCIN VERSUS ADRIAMYCIN ALTERNATED WITH MITOMYCIN-C IN THE TREATMENT OF SURFACE BLADDER-CANCER - RANDOMIZED STUDY
    BELMONTE, P
    BO, VD
    MERLO, A
    FIACCAVENTO, G
    VERONESI, A
    VOLPE, R
    CARBONE, A
    ROSSETTI, F
    FRANCINI, M
    MONFARDINI, S
    TUMORI, 1986, 72 (06) : 687 - 687
  • [38] Intraoperative mitomycin-C versus postoperative topical mitomycin-C drops for the treatment of pterygium
    Helal, M
    Messiha, N
    Amayem, A
    ElMaghraby, A
    Elsherif, Z
    Dabees, M
    OPHTHALMIC SURGERY AND LASERS, 1996, 27 (08): : 674 - 678
  • [39] STUDY OF CTL AND LAK CONTACTS TO TARGET-CELLS AFTER TREATMENT WITH MITOMYCIN-C AND ADRIAMYCIN
    FOA, C
    GALINDO, G
    BENOLIEL, AM
    CAPO, C
    MEGE, JL
    BONGRAND, P
    LEROUX, JY
    OTH, D
    IMMUNOLOGICAL INVESTIGATIONS, 1987, 16 (03) : 241 - 262
  • [40] INHIBITION OF ADRIAMYCIN (AD) AND MITOMYCIN-C (M) MUTAGENESIS (MUT) BY MENADIONE (K3)
    BLOCK, JB
    DIETRICH, M
    TSUNOKAI, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 125 - 125
12345